Breast implant-associated anaplastic large cell lymphoma: Report of 2 cases and review of the literature

Aesthetic Surgery Journal

Volumn 34, Issue 6, 2014, Pages 884-894

  Hart, Alexandra M ^a   Lechowicz, Mary Jo ^a   Peters, Kendall K ^b   Holden, Jeannine ^b   Carlson, Grant W ^a  

^a EMORY UNIVERSITY   (United States)

^b Department of Hematology and Medical Oncology Winship Cancer Institute ^*

Author keywords

anaplastic lymphoma; breast augmentation; breast cancer; breast implant; breast lymphoma; breast reconstruction

Indexed keywords

SILICONE GEL; SODIUM CHLORIDE; SILICONE DERIVATIVE;

ADULT; BREAST AUGMENTATION; BREAST IMPLANT; BREAST SURGERY; CASE REPORT; CHROMOSOME ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DUODENUM BIOPSY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; ADVERSE DEVICE EFFECT; AGED; ANAPLASTIC LARGE CELL LYMPHOMA; BIOPSY; BREAST TUMOR; DEVICE REMOVAL; DEVICES; DIAGNOSTIC IMAGING; ECHOMAMMOGRAPHY; MIDDLE AGED; PROSTHESIS DESIGN; RISK FACTOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; DEVICE REMOVAL; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PROSTHESIS DESIGN; RISK FACTORS; SILICONES; SODIUM CHLORIDE; TREATMENT OUTCOME; ULTRASONOGRAPHY, MAMMARY; YOUNG ADULT;

EID: 84905495718     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1177/1090820X14539503     Document Type: Review

References (71)

1. Keech JA, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997 ; 100: 554-555
2. Cohen PL, Brooks JJ. Lymphomas of the breast: a clinicopathologic and immunohistochemical study of primary and secondary cases. Cancer. 1991 ; 67: 1359-1369
3. Thompson PA, Lade S, Webster H, Ryan G, Prince HM. Effusion-associated anaplastic large cell lymphoma of the breast: time for it to be defined as a distinct clinico-pathological entity. Haematologica. 2010 ; 95: 1977-1999
4. Eaves F, Nahai F. Anaplastic large cell lymphoma and breast implants: FDA report. Aesthet Surg J. 2011 ; 31: 467-468
5. Aladily TN, Medeiros LJ, Amin MB, et al. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol. 2012 ; 36: 1000-1008
6. Alobeid B, Sevilla DW, El-Tamer MB, Murty VV, Savage DG, Bhagat G. Aggressive presentation of breast implant-associated ALK-1 negative anaplastic large cell lymphoma with bilateral axillary lymph node involvement. Leuk Lymphoma. 2009 ; 50: 831-883
7. Bishara MR, Ross C, Sur M. Primary anaplastic large cell lymphoma of the breast arising in reconstruction mammoplasty capsule of saline filled breast implant after radical mastectomy for breast cancer: an unusual case presentation. Diagn Pathol. 2009 ; 4: 11
8. Carty MJ, Pribaz JJ, Antin JH, et al. A patient death attributable to implant-related primary anaplastic large cell lymphoma of the breast. Plast Reconstr Surg. 2011 ; 128: 112e - 118e
9. de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA. 2008 ; 300: 2030-2035
10. De Silva IM, Teague JA, Blake WE. Breast implant associated anaplastic large cell lymphoma: a case report and reconstructive option. J Plast Reconstr Aesthet Surg. 2013 ; 66: 1773-1776
11. Do V, Shifrin DA, Oostendorp L. Lymphoma of the breast capsule in a silicone implant-reconstructed patient. Am Surg. 2010 ; 76: 1030-1031
12. Farace F, Bulla A, Marongiu F, et al. Anaplastic large cell lymphoma of the breast arising around mammary implant capsule: an Italian report. Aesthetic Plast Surg. 2013 ; 37: 567-571
13. Farkash EA, Ferry JA, Harris NL, et al. Rare lymphoid malignancies of the breast: a report of two cases illustrating potential diagnostic pitfalls. J Hematop. 2009 ; 2: 237-244
14. Fritzsche FR, Pahl S, Petersen I, et al. Anaplastic large-cell non-Hodgkin's lymphoma of the breast in periprosthetic localisation 32 years after treatment for primary breast cancer: a case report. Virchows Arch. 2006 ; 449: 561-564
15. Gaudet G, Friedberg JW, Weng A, Pinkus GS, Freedman AS. Breast lymphoma associated with breast implants: two case-reports and a review of the literature. Leuk Lymphoma. 2002 ; 43: 115-119
16. Gualco G, Chioato L, Harrington WJ, Weiss LM, Bacchi CE. Primary and secondary T-cell lymphomas of the breast: clinico-pathologic features of 11 cases. Appl Immunohistochem Mol Morphol. 2009 ; 17: 301-306
17. Hanson SE, Gutowski KA. Primary T-cell lymphoma associated with breast implant capsule. Plast Reconstr Surg. 2010 ; 126: 39e - 41e
18. Ivaldi C, Perchenet AS, Jallut Y, Casanova D. [About two cases of lymphoma in implant capsule: a difficult diagnosis, an unknown pathology]. Ann Chir Plast Esthet. 2013 ; 58: 688-693
19. Lazzeri D, Agostini T, Bocci G, et al. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer. 2011 ; 11: 283-296
20. Lechner MG, Lade S, Liebertz DJ, et al. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity. Cancer. 2011 ; 117: 1478-1489
21. Lee M, Cooper B, Becker D. Keeping abreast of axillary masses. Lancet. 2012 1530 ; 380 ( 9852 ):
22. Li S, Lee AK. Silicone implant and primary breast ALK1-negative anaplastic large cell lymphoma, fact or fiction?. Int J Clin Exp Pathol. 2009 ; 3: 117-127
23. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of 6 cases and review of the literature. Arch Pathol Lab Med. 2009 ; 133: 1383-1390
24. Mora P, Melo AC, Amorim GLS, Scheliga AA. Primary T-cell anaplastic lymphoma associated to a breast implant: case report. Haematologica. 2009 ; 94: 658
25. Newman MK, Zemmel NJ, Bandak AZ, Kaplan BJ. Primary breast lymphoma in a patient with silicone breast implants: a case report and review of the literature. J Plast Reconstr Aesthet Surg. 2008 ; 61: 822-825
26. Olack B, Gupta R, Brooks GS. Anaplastic large cell lymphoma arising in a saline breast implant capsule after tissue expander breast reconstruction. Ann Plast Surg. 2007 ; 59: 56-57
27. Popplewell L, Thomas SH, Huang Q, Chang KL, Forman SJ. Primary anaplastic large-cell lymphoma associated with breast implants. Leuk Lymphoma. 2004 ; 52: 1481-1487
28. Roden AC, Macon WR, Keeney GL, Myers JL, Feldman AL, Dogan A. Seroma-associated primary anaplastic large-cell lymphoma adjacent to breast implants: an indolent T-cell lymphoproliferative disorder. Mod Pathol. 2008 ; 21: 455-463
29. Sahoo S, Rosen PP, Feddersen RM, Viswanatha DS, Clark DA, Chadburn A. Anaplastic large cell lymphoma arising in a silicone breast implant capsule: a case report and review of the literature. Arch Pathol Lab Med. 2003 ; 127 (3). e115 - e118
30. Smith TJ, Ramsaroop R. Breast implant related anaplastic large cell lymphoma presenting as late onset peri-implant effusion. Breast. 2012 ; 21: 102-104
31. Taylor KO, Webster HR, Prince HM. Anaplastic large cell lymphoma and breast implants: five Australian cases. Plast Reconstr Surg. 2012 ; 129: 610e - 617e
32. Thompson PA, Prince HM. Breast implant-associated anaplastic large cell lymphoma: a systematic review of the literature and mini-meta analysis. Curr Hematol Malig Rep. 2013 ; 8: 196-210
33. Wong AK, Lopategui J, Clancy S, Kulber D, Bose S. Anaplastic large cell lymphoma associated with a breast implant capsule: a case report and review of the literature. Am J Surg Pathol. 2008 ; 32: 1265-1268
34. George EV, Pharm J, Houston C, et al. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis. Int J Clin Exp Pathol. 2013 ; 6: 1631-1642
35. Lazzeri D, Agostini T, Giannotti G, et al. Null-type anaplastic lymphoma kinase-negative anaplastic large cell lymphoma arising in a silicone breast implant capsule. Plast Reconstr Surg. 2011 ; 127: 159e - 162e
36. Brinton LA, Lubin JH, Burich MC, Colton T, Brown SL, Hoover RN. Cancer risk at sites other than the breast following augmentation mammoplasty. Ann Epidemiol. 2001 ; 11: 248-256
37. Brisson J, Holowaty EJ, Villeneuve PJ, et al. Cancer incidence in a cohort of Ontario and Quebec women having bilateral breast augmentation. Int J Cancer. 2006 ; 118: 2854-2862
38. Deapen DM, Hirsch EM, Brody GS. Cancer risk among Los Angeles women with cosmetic breast implants. Plast Reconstr Surg. 2007 ; 119: 1987-1992
39. Lipworth L, Tarone RE, Friis S, et al. Cancer among Scandinavian women with cosmetic breast implants: a pooled long-term follow-up study. Int J Cancer. 2009 ; 124: 490-493
40. Lipworth L, Tarone RE, McLaughlin JK. Breast implants and lymphoma risk: a review of the epidemiologic evidence through 2008. Plast Reconstr Surg. 2009 ; 123: 790-793
41. Pukkala E, Boice JD, Hovi SL, et al. Incidence of breast and other cancers among Finnish women with cosmetic breast implants, 1970-1999. J Long Term Eff Med Implants. 2002 ; 12: 271-279
42. Jaffe ES, ed. Lyon, France: IARC Press ; 2001 :
43. Kinney MC, Higgins RA, Medina EA. Anaplastic large cell lymphoma: twenty-five years of discovery. Arch Pathol Lab Med. 2011 ; 135: 19-43
44. Stein H, Foss HD, Dürkop H, et al. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features. Blood. 2000 ; 96: 3681-3695
45. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005 ; 105: 3768-3785
46. Harris NL, Jaffe ES, Diebold J, et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. Ann Oncol. 1999 ; 10: 1419-1432
47. Duvic M, Moore D, Menter A, Vonderheid EC. Cutaneous T-cell lymphoma in association with silicone breast implants. J Am Acad Dermatol. 1995 ; 32: 939-942
48. Kupper TS, Fuhlbrigge RC. Immune surveillance in the skin: mechanisms and clinical consequences. Nat Rev Immunol. 2004 ; 4: 211-222
49. Lamant L, Pileri S, Sabattini E, Brugières L, Jaffe ES, Delsol G. Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases. Haematologica. 2010 ; 95: 449-455
50. Palraj B, Paturi A, Stone RG, et al. Soft tissue anaplastic large T-cell lymphoma associated with a metallic orthopedic implant: case report and review of the current literature. J Foot Ankle Surg. 2010 ; 49: 561-564
51. Kadin M, Xu H, Pavlov I, et al. Breast implant associated ALCL closely resembles primary cutaneous ALCL. Lab Investig. 2012 ; 92: 346A
52. Kim B, Roth C, Young VL, et al. Anaplastic large cell lymphoma and breast implants: results from a structured expert consultation process. Plast Reconstr Surg. 2011 ; 128: 629-639
53. Wolfram D, Rainer C, Niederegger H, Piza H, Wick G. Cellular and molecular composition of fibrous capsules formed around silicone breast implants with special focus on local immune reactions. J Autoimmun. 2004 ; 23: 81-91
54. Prantl L, Schreml S, Fichtner-Feigl S, et al. Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg. 2007 ; 120: 275-284
55. de la Pena-Salcedo JA, Soto-Miranda MA, Lopez-Salguero JF. Back to the future: a 15-year experience with polyurethane foam-covered breast implants using the partial-subfascial technique. Aesthetic Plast Surg. 2012 ; 36: 331-338
56. Handel N, Gutierrez J. Long-term safety and efficacy of polyurethane foam-covered breast implants. Aesthet Surg J. 2006 ; 26: 265-274
57. Batich C, Williams J. Toxic hydrolysis product from biodegradable foam implant. J Biomed Mater Res. 1989 ; 23: 311-319
58. Barnsley GP, Sigurdson LJ, Barnsley SE. Textured surface breast implants in the prevention of capsular contracture among breast augmentation patients: a meta-analysis of randomized controlled trials. Plast Reconstr Surg. 2006 ; 117: 2182-2190
59. Wong CH, Samuel M, Tan BK, Song C. Capsular contracture in subglandular breast augmentation with textured versus smooth breast implants: a systematic review. Plast Reconstr Surg. 2006 ; 118: 1224-1236
60. Maxwell GP, Falcone PA. Eighty-four consecutive breast reconstructions using a textured silicone tissue expander. Plast Reconstr Surg. 1992 ; 89: 1022-1034
61. Barr S, Bayat A. Breast implant surface development: perspectives on development and manufacture. Aesthet Surg J. 2011 ; 31: 56-67
62. Lechner MG, Megiel C, Church CH, et al. Survival signals and targets for therapy in breast implant-associated ALK: anaplastic large cell lymphoma. Clin Cancer Res. 2012 ; 18: 4549-4559
63. Meza Britez ME, Caballero Llano C, Chaux A. Periprosthetic breast capsules and immunophenotypes of inflammatory cells. Eur J Plast Surg. 2012 ; 35: 647-651
64. Adams WP, Bengston BP, Glicksman CA, et al. Decision and management algorithms to address patient and food and drug administration concerns regarding breast augmentation and implants. Plast Reconstr Surg. 2004 ; 114: 1252-1257
65. Mazzocchi M, Dessy LA, Carlesimo B, Marchetti F, Scuderi N. Late seroma formation after breast surgery with textured silicone implants: a problem worth bearing in mind. Plast Reconstr Surg. 2010 ; 125: 176e - 177e
66. Pinchuk V, Tymofii O. Seroma as a late complication after breast augmentation. Aesthetic Plast Surg. 2011 ; 35: 303-314
67. Hall-Findlay EJ. Breast implant complication review: double capsules and late seromas. Plast Reconstr Surg. 2011 ; 127: 56-66
68. Spear SL, Rottman SJ, Glicksman C, Brown M, Al-Attar A. Late seromas after breast implants: theory and practice. Plast Reconstr Surg. 2012 ; 130: 423-435
69. Bengtson B, Brody GS, Brown MH, et al. Managing late periprosthetic fluid collections (seroma) in patients with breast implants: a consensus panel recommendation and review of the literature. Plast Reconstr Surg. 2011 ; 128: 1-7
70. Taylor CR, Siddiqi IN, Brody GS. Anaplastic large cell lymphoma occurring in association with breast implants: review of pathologic and immunohistochemical features in 103 cases. Appl Immunohistochem Mol Morphol. 2013 ; 21: 13-20
71. Washington, DC: US Department of Health and Human Services ; 2013 :